These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10805114)

  • 1. Low-dose dobutamine gated single-photon emission tomography: comparison with stress echocardiography.
    Everaert H; Vanhove C; Franken PR
    Eur J Nucl Med; 2000 Apr; 27(4):413-8. PubMed ID: 10805114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of perfusion, function, and myocardial metabolism after infarction with a combination of low-dose dobutamine tetrofosmin gated SPECT perfusion scintigraphy and BMIPP SPECT imaging.
    Everaert H; Vanhove C; Franken PR
    J Nucl Cardiol; 2000; 7(1):29-36. PubMed ID: 10698232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of beta-blockade on low-dose dobutamine-induced changes in left ventricular function in healthy volunteers: assessment by gated SPET myocardial perfusion scintigraphy.
    Everaert H; Vanhove C; Franken PR
    Eur J Nucl Med; 2000 Apr; 27(4):419-24. PubMed ID: 10805115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET.
    Yoshinaga K; Katoh C; Noriyasu K; Yamada S; Ito Y; Kuge Y; Kawai Y; Kohya T; Kitabatake A; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):882-90. PubMed ID: 12111128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low-dose dobutamine on left ventricular function in normal subjects as assessed by gated single-photon emission tomography myocardial perfusion studies.
    Everaert H; Vanhove C; Franken PR
    Eur J Nucl Med; 1999 Oct; 26(10):1298-303. PubMed ID: 10541828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of low-dose dobutamine addition to routine dual isotope gated SPECT myocardial imaging in patients with healed myocardial infarction or abnormal wall thickening by echocardiogram.
    Heiba SI; Abdel-Dayem HM; Gould R; Bernaski E; Morlote M; El-Zeftawy H; Ambrose JA
    Am J Cardiol; 2004 Feb; 93(3):300-6. PubMed ID: 14759378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of regional dysfunction from gated single photon emission tomography myocardial perfusion studies: a non-segmental approach.
    Everaert H; Vanhove C; Schoors D; Dendale P; Franken PR
    Nucl Med Commun; 1999 Apr; 20(4):335-43. PubMed ID: 10319353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gated SPET myocardial perfusion acquisition within 5 minutes using focussing collimators and a three-head gamma camera.
    Everaert H; Vanhove C; Franken PR
    Eur J Nucl Med; 1998 Jun; 25(6):587-93. PubMed ID: 9618572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose dobutamine nitrate-enhanced technetium 99m sestamibi gated SPECT versus low-dose dobutamine echocardiography for detecting reversible dysfunction in ischemic cardiomyopathy.
    Leoncini M; Sciagrà R; Bellandi F; Maioli M; Sestini S; Marcucci G; Coppola A; Frascarelli F; Mennuti A; Dabizzi RP
    J Nucl Cardiol; 2002; 9(4):402-6. PubMed ID: 12161716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.
    Yoshinaga K; Morita K; Yamada S; Komuro K; Katoh C; Ito Y; Kuge Y; Kohya T; Kitabatake A; Tamaki N
    J Nucl Med; 2001 Jun; 42(6):838-44. PubMed ID: 11390545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in myocardial Tc-99m-sestamibi uptake in asynergic territories during low-dose echo-dobutamine test].
    Leoncini M; Marcucci G; Magni M; Silvestri M; Traini AM; Arena A; Mondanelli D; Giovannini T; Paoletti M; Bardazzi L; Mennuti A; Petrella A
    G Ital Cardiol; 1996 Nov; 26(11):1243-55. PubMed ID: 9036021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrate-enhanced gated technetium 99m sestamibi SPECT for evaluating regional wall motion at baseline and during low-dose dobutamine infusion in patients with chronic coronary artery disease and left ventricular dysfunction: comparison with two-dimensional echocardiography.
    Leoncini M; Marcucci G; Sciagrà R; Frascarelli F; Traini AM; Mondanelli D; Magni M; Bini L; Bellandi F; Mennuti A; Dabizzi RP
    J Nucl Cardiol; 2000; 7(5):426-31. PubMed ID: 11083190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of rest technetium-99m sestamibi SPET and low-dose dobutamine stress echocardiography for the early assessment of myocardial viability after acute myocardial infarction: importance of the severity of the infarct-related stenosis.
    Claeys MJ; Rademakers FE; Vrints CJ; Krug B; Bosmans JM; Conraads V; Bossaert LL; Snoeck JP; Blockx PP
    Eur J Nucl Med; 1996 Jul; 23(7):748-55. PubMed ID: 8662112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular dysfunction and healed myocardial infarction.
    Rambaldi R; Poldermans D; Bax JJ; Boersma E; Valkema R; Elhendy A; Vletter WB; Fioretti PM; Roelandt JR; Krenning EP
    Am J Cardiol; 1999 Jul; 84(2):130-4. PubMed ID: 10426327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of 99Tcm-sestamibi gated SPET for long-term myocardial perfusion and functional recovery after an acute myocardial infarction.
    Solà M; Magriñà J; García A; Pavía J; Vidal-Sicart S; Huguet M; Paré C; Azqueta M; Setoain J
    Nucl Med Commun; 1998 Sep; 19(9):823-30. PubMed ID: 10581588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of residual wall motion after myocardial infarction by gated technetium-99m tetrofosmin SPET: a comparison with contrast ventriculography.
    Wahba FF; Dibbets-Schneider P; Bax JJ; Bavelaar-Croon CD; Zwinderman AH; Pauwels EK; van der Wall EE
    Eur J Nucl Med; 2001 Apr; 28(4):514-21. PubMed ID: 11357503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single Tc99m Sestamibi injection, double acquisition gated SPECT after stress and during low-dose dobutamine infusion: a new suggested protocol for evaluation of myocardial perfusion.
    Fallahi B; Beiki D; Gholamrezanezhad A; Mahmoudian B; Ansari Gilani K; Eftekhari M; Fard-Esfahani A; Mohseni Z; Saghari M
    Int J Cardiovasc Imaging; 2008 Dec; 24(8):825-35. PubMed ID: 18563624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of baseline and low-dose dobutamine technetium-99m sestamibi scintigraphy with low-dose dobutamine echocardiography for predicting functional recovery after revascularization.
    Leoncini M; Marcucci G; Sciagrà R; Mondanelli D; Traini AM; Magni M; Frascarelli F; Mennuti A; Dabizzi RP
    Am J Cardiol; 2000 Jul; 86(2):153-7. PubMed ID: 10913475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of contractility of viable myocardium during inotropic stimulation is not dependent on an increase of myocardial blood flow in the absence of collateral filling.
    Barillà F; De Vincentis G; Mangieri E; Ciavolella M; Panitteri G; Scopinaro F; Critelli G; Campa PP
    J Am Coll Cardiol; 1999 Mar; 33(3):697-704. PubMed ID: 10080470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dobutamine stress electrocardiography-gated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium.
    Yamagishi H; Akioka K; Hirata K; Sakanoue Y; Toda I; Yoshiyama M; Teragaki M; Takeuchi K; Yoshikawa J; Ochi H
    J Nucl Cardiol; 2001; 8(1):58-67. PubMed ID: 11182710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.